ESCA

Escalade, Incorporated

66
Fundamentals75/ 100
Valuation59/ 100
Upside potential58/ 100
Risk potential20/ 100

ESCA has the edge over LCID overall, supported by lower modeled downside and stronger fundamentals.

LCID

Lucid Group, Inc.

52
Fundamentals65/ 100
Valuation50/ 100
Upside potential62/ 100
Risk potential38/ 100

LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.

ESCA Fundamentals

MetricStatus
Stable
Strong
Strong
Strong

ESCA's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.

LCID Fundamentals

MetricStatus
Healthy
Weak
Weak
Unavailable

LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.

ESCA PE Valuation

CHEAPFAIREXPENSIVE7.9x16x24x32x
CHEAPFAIREXPENSIVE7.9x16x24x32x
LevelPEPriceVs current
Cheap8.9x$15.66-25%
Current12x$20.99—
Fair14x$24.67+18%
Expensive18x$30.70+46%

Historical ranges are pointers, not guarantees.

ESCA's PE is in its fair range at 12x.

LCID PE Valuation

LCID has no meaningful PE right now: it lost money over the past year.

ESCA Forward outlook

There aren't enough analyst estimates for ESCA to show an outlook.

LCID Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
--
Limited
Low

Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

ESCA Risk to reward

ScenarioChangePrice
Upside+29%$26.98
Downside-20%$16.69

Calculated from the latest close: $20.99 on Nov 12.

ESCA trails LCID on modeled risk to reward, with less potential upside relative to its potential downside.

LCID Risk to reward

ScenarioChangePrice
Upside+63%$5.30
Downside-38%$2.02

Calculated from the latest close: $3.25 on Nov 12.

LCID has a better modeled risk to reward balance than ESCA, with more potential upside relative to its potential downside.

ESCA Earnings Per Share

Q4 2023: $0.71Q1 2024: $0.91Q2 2024: $0.85Q3 2024: $0.94Q4 2024: $0.93Q1 2025: $0.99Q2 2025: $0.92Q3 2025: $0.92Q4 2025: $0.99Q1 2026: $1.12Q2 2026: $1.67Q3 2026: $1.75
Q4 2023: $0.71Q1 2024: $0.91Q2 2024: $0.85Q3 2024: $0.94Q4 2024: $0.93Q1 2025: $0.99Q2 2025: $0.92Q3 2025: $0.92Q4 2025: $0.99Q1 2026: $1.12Q2 2026: $1.67Q3 2026: $1.75
QuarterTTM EPSYoY
Q3 2026$1.75+90%
Q2 2026$1.67+82%
Q1 2026$1.12+13%
Q4 2025$0.99+6.5%
Q3 2025$0.92-2.1%
Q2 2025$0.92+8.2%
Q1 2025$0.99+8.8%
Q4 2024$0.93+31%

ESCA has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.

LCID Earnings Per Share

Q4 2023: $-13.60Q1 2024: $-12.30Q2 2024: $-11.70Q3 2024: $-13.00Q4 2024: $-12.50Q1 2025: $-11.90Q2 2025: $-11.30Q3 2025: $-10.51Q4 2025: $-12.09Q1 2026: $-13.15Q2 2026: $-13.65Q3 2026: $-13.08
Q4 2023: $-13.60Q1 2024: $-12.30Q2 2024: $-11.70Q3 2024: $-13.00Q4 2024: $-12.50Q1 2025: $-11.90Q2 2025: $-11.30Q3 2025: $-10.51Q4 2025: $-12.09Q1 2026: $-13.15Q2 2026: $-13.65Q3 2026: $-13.08
QuarterTTM EPSYoY
Q3 2026-$13.08-$2.57
Q2 2026-$13.65-$2.35
Q1 2026-$13.15-$1.25
Q4 2025-$12.09+$0.41
Q3 2025-$10.51+$2.49
Q2 2025-$11.30+$0.40
Q1 2025-$11.90+$0.40
Q4 2024-$12.50+$1.10

LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.

ESCA Quarterly Revenue

Q4 2023: $66MQ1 2024: $57MQ2 2024: $63MQ3 2024: $68MQ4 2024: $64MQ1 2025: $55MQ2 2025: $54MQ3 2025: $68MQ4 2025: $63MQ1 2026: $56MQ2 2026: $58MQ3 2026: $66M
Q4 2023: $66MQ1 2024: $57MQ2 2024: $63MQ3 2024: $68MQ4 2024: $64MQ1 2025: $55MQ2 2025: $54MQ3 2025: $68MQ4 2025: $63MQ1 2026: $56MQ2 2026: $58MQ3 2026: $66M
QuarterRevenueYoY
Q3 2026$65.6M-3.2%
Q2 2026$57.7M+6.2%
Q1 2026$55.8M+0.6%
Q4 2025$62.6M-2.2%
Q3 2025$67.8M+0.1%
Q2 2025$54.3M-13%
Q1 2025$55.5M-3.2%
Q4 2024$63.9M-2.4%

ESCA's revenue fell from its 2021 peak and has held roughly level since: $66M last quarter, down 3.2% from the same quarter a year ago.

LCID Quarterly Revenue

Q4 2023: $157MQ1 2024: $173MQ2 2024: $201MQ3 2024: $200MQ4 2024: $234MQ1 2025: $235MQ2 2025: $259MQ3 2025: $337MQ4 2025: $523MQ1 2026: $282MQ2 2026: $405MQ3 2026: $350M
Q4 2023: $157MQ1 2024: $173MQ2 2024: $201MQ3 2024: $200MQ4 2024: $234MQ1 2025: $235MQ2 2025: $259MQ3 2025: $337MQ4 2025: $523MQ1 2026: $282MQ2 2026: $405MQ3 2026: $350M
QuarterRevenueYoY
Q3 2026$350.3M+4.1%
Q2 2026$405.3M+56%
Q1 2026$282.5M+20%
Q4 2025$522.7M+123%
Q3 2025$336.6M+68%
Q2 2025$259.4M+29%
Q1 2025$235M+36%
Q4 2024$234.5M+49%

LCID has the edge over ESCA on sales, with more consistent year-over-year improvement.

ESCA Free Cash Flow

Q4 2023: $20MQ1 2024: −$350,000Q2 2024: $12MQ3 2024: $10MQ4 2024: $12MQ1 2025: $3MQ2 2025: $13MQ3 2025: −$1MQ4 2025: $14MQ1 2026: $5MQ2 2026: $8MQ3 2026: $14M
Q4 2023: $20MQ1 2024: −$350,000Q2 2024: $12MQ3 2024: $10MQ4 2024: $12MQ1 2025: $3MQ2 2025: $13MQ3 2025: −$1MQ4 2025: $14MQ1 2026: $5MQ2 2026: $8MQ3 2026: $14M
QuarterFree cash flowYoY
Q3 2026$14M+$15.2M
Q2 2026$8.2M-36%
Q1 2026$5.3M+63%
Q4 2025$13.7M+16%
Q3 2025-$1.3M-112%
Q2 2025$12.9M+3.1%
Q1 2025$3.2M+$3.6M
Q4 2024$11.7M-42%

ESCA has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.

LCID Free Cash Flow

Q4 2023: −$747MQ1 2024: −$715MQ2 2024: −$741MQ3 2024: −$622MQ4 2024: −$825MQ1 2025: −$590MQ2 2025: −$1BQ3 2025: −$955MQ4 2025: −$1.2BQ1 2026: −$1.4BQ2 2026: −$1.5BQ3 2026: −$1B
Q4 2023: −$747MQ1 2024: −$715MQ2 2024: −$741MQ3 2024: −$622MQ4 2024: −$825MQ1 2025: −$590MQ2 2025: −$1BQ3 2025: −$955MQ4 2025: −$1.2BQ1 2026: −$1.4BQ2 2026: −$1.5BQ3 2026: −$1B
QuarterFree cash flowYoY
Q3 2026-$1B-$84.2M
Q2 2026-$1.5B-$463.2M
Q1 2026-$1.4B-$849M
Q4 2025-$1.2B-$417.1M
Q3 2025-$955.5M-$333M
Q2 2025-$1B-$271.6M
Q1 2025-$589.9M+$125.1M
Q4 2024-$824.8M-$77.6M

LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.

ESCA Total Shares

Q4 2023: 14MQ1 2024: 14MQ2 2024: 14MQ3 2024: 14MQ4 2024: 14MQ1 2025: 14MQ2 2025: 14MQ3 2025: 14MQ4 2025: 14MQ1 2026: 14MQ2 2026: 14MQ3 2026: 14M
Q4 2023: 14MQ1 2024: 14MQ2 2024: 14MQ3 2024: 14MQ4 2024: 14MQ1 2025: 14MQ2 2025: 14MQ3 2025: 14MQ4 2025: 14MQ1 2026: 14MQ2 2026: 14MQ3 2026: 14M
PeriodChange %Net change
Quarterly0%+1K shares
1 year+0.2%+31K shares
3 years+0.1%+15K shares
5 years+0.7%+94K shares
Available history-3.7%-537K shares

ESCA has the edge over LCID on shareholder dilution, with a more favorable share count trend.

LCID Total Shares

Q4 2023: 208MQ1 2024: 230MQ2 2024: 231MQ3 2024: 232MQ4 2024: 245MQ1 2025: 304MQ2 2025: 306MQ3 2025: 312MQ4 2025: 313MQ1 2026: 328MQ2 2026: 382MQ3 2026: 395M
Q4 2023: 208MQ1 2024: 230MQ2 2024: 231MQ3 2024: 232MQ4 2024: 245MQ1 2025: 304MQ2 2025: 306MQ3 2025: 312MQ4 2025: 313MQ1 2026: 328MQ2 2026: 382MQ3 2026: 395M
PeriodChange %Net change
Quarterly+3.3%+12.5M shares
1 year+26%+82.4M shares
3 years+73%+166M shares

LCID has 395M diluted shares, up 26% from a year ago.

ESCA Net Leverage

Q4 2023: 2.2xQ1 2024: 2.0xQ2 2024: 1.7xQ3 2024: 1.1xQ4 2024: 0.8xQ1 2025: 0.8xQ2 2025: 0.5xQ3 2025: 0.7xQ4 2025: 0.3xQ1 2026: 0.1xQ2 2026: -0.0xQ3 2026: -0.3x
Q4 2023: 2.2xQ1 2024: 2.0xQ2 2024: 1.7xQ3 2024: 1.1xQ4 2024: 0.8xQ1 2025: 0.8xQ2 2025: 0.5xQ3 2025: 0.7xQ4 2025: 0.3xQ1 2026: 0.1xQ2 2026: -0.0xQ3 2026: -0.3x
QuarterNet LeverageStatus
Q3 2026-0.3xNet Cash
Q2 2026-0.0xNet Cash
Q1 20260.1xVery low
Q4 20250.3xVery low
Q3 20250.7xVery low
Q2 20250.5xVery low
Q1 20250.8xVery low
Q4 20240.8xVery low

ESCA has more cash than debt.

LCID Net Leverage

LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

ESCA Weekly Momentum

MetricValueStatus
RSI60.3Neutral
Stochastic49.4Neutral

ESCA's weekly RSI is 60 (neutral) and its Stochastic is 49 (neutral).

LCID Weekly Momentum

MetricValueStatus
RSI32.9Neutral
Stochastic7.1Oversold

LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).

ESCA PE vs Consumer Cyclical Sector

MetricESCASector medianRelative
PE12x18x33% below
PE %364711 pts below

ESCA is trading at 12x earnings, a 33% discount to the Consumer Cyclical sector's median of 18x.

LCID PE vs Consumer Cyclical Sector

LCID has no meaningful PE right now: it lost money over the past year.

ESCA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$19.57.8% above
20 week MA$19.76.4% above
50 week MA$17.619% above
100 week MA$15.733% above
200 week MA$15.338% above

ESCA has the edge over LCID on trend strength, trading above more of its moving averages.

LCID Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.537.9% below
20 week MA$4.8833% below
50 week MA$7.3356% below
100 week MA$15.479% below
200 week MA$31.990% below

LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.

ESCA Yearly ROI

YearStart priceEnd priceROI
2020$9.79$21.7+122%
2021$21.7$15.7-28%
2022$15.7$9.81-37%
2023$9.81$20.1+105%
2024$20.1$14.4-29%
2025$14.4$13.4-6.8%
2026 YTD$13.4$21.0+57%

ESCA has the edge over LCID on returns for 2026, with the stronger performance.

LCID Yearly ROI

YearStart priceEnd priceROI
2020$98.9$100.4+1.5%
2021$100.4$376.4+275%
2022$376.4$67.0-82%
2023$67.0$42.1-37%
2024$42.1$32.0-24%
2025$32.0$11.4-64%
2026 YTD$11.4$3.25-72%

LCID has finished four years in a row lower, and it's down 72% so far in 2026.

Give your agent the market.

Get API key